Unclear and often mixed messages have contributed to public confusion that has arguably placed people’s health at risk.
At this stage it’s hard to know for sure why Melbourne’s COVID numbers are higher, but it’s likely that climate plays a role.
There are three measures for assessing whether public policy is successful, and the Coalition has been found wanting on all three. But there’s one policy area that’s an even bigger disaster.
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
The rare blood-clotting issues associated with the Astra-Zeneca vaccine have recently made headlines, but it's too early to say whether it will increase overall vaccine hesitancy.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
We'll struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
Dummy text